Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$37.26 - $67.74 $75.4 Million - $137 Million
-2,022,619 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$45.01 - $65.47 $1.41 Million - $2.05 Million
-31,363 Reduced 1.53%
2,022,619 $120 Million
Q3 2020

Nov 12, 2020

SELL
$35.79 - $48.81 $601,128 - $819,812
-16,796 Reduced 0.81%
2,053,982 $99.9 Million
Q2 2020

Aug 12, 2020

BUY
$24.95 - $48.38 $4.93 Million - $9.57 Million
197,743 Added 10.56%
2,070,778 $100 Million
Q1 2020

May 12, 2020

BUY
$16.96 - $34.16 $31.8 Million - $64 Million
1,873,035 New
1,873,035 $52 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.